Also trades as: EFTRW (NASDAQ) · $vol 0M
EFTR OTC
eFFECTOR Therapeutics, Inc.
1W: +0.0%
1M: -75.0%
3M: -66.7%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$30M
-14.1% ▼
Capital Expenditures
$97K
+49.5% ▲
4Y CAGR: +121.9%
Free Cash Flow
-$30M
-13.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$6M
+115.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$30M | $14M | $16M | -$23M | -$36M |
| Depreciation & Amort. | $307K | $160K | $24K | $53K | $111K |
| Stock-Based Comp. | $646K | $499K | $9M | $5M | $5M |
| Change in Working Capital | $1M | -$824K | -$238K | $3M | $2M |
| Other Non-Cash Items | $2M | $122K | -$49M | -$11M | -$130K |
| Operating Cash Flow | -$28M | $14M | -$25M | -$26M | -$30M |
| — Investing Activities — | |||||
| Capital Expenditures | -$4K | -$154K | -$42K | -$192K | -$97K |
| Acquisitions (Net) | $88K | $0 | $607K | $18M | $0 |
| Investment Purchases | $0 | $0 | $0 | -$52M | -$17M |
| Investment Sales | $0 | $0 | $0 | $35M | $32M |
| Other Investing | $0 | $0 | $0 | -$18M | $0 |
| Investing Cash Flow | $84K | -$154K | $565K | -$18M | $14M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$2M | $6M | $0 | $0 |
| Stock Repurchased | -$86K | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $20M | $0 | $53M | -$34K | $56K |
| Financing Cash Flow | $20M | -$2M | $59M | $3M | $21M |
| Net Change in Cash | $3M | $12M | $34M | -$41M | $6M |
| Cash End of Period | $3M | $15M | $50M | $9M | $15M |
| Free Cash Flow | -$28M | $14M | -$25M | -$26M | -$30M |